These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32065802)

  • 1. Neuromelanin Magnetic Resonance Imaging of the Substantia Nigra in Huntington's Disease.
    Leitão R; Guerreiro C; Nunes RG; Gonçalves N; Galati G; Rosário M; Guedes LC; Ferreira JJ; Reimão S
    J Huntingtons Dis; 2020; 9(2):143-148. PubMed ID: 32065802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nigral involvement and nigrostriatal dysfunction in Huntington's disease: evidences from an MRI and SPECT study.
    Kiferle L; Mazzucchi S; Unti E; Pesaresi I; Fabbri S; Nicoletti V; Volterrani D; Cosottini M; Bonuccelli U; Ceravolo R
    Parkinsonism Relat Disord; 2013 Sep; 19(9):800-5. PubMed ID: 23769177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease.
    Fabbri M; Reimão S; Carvalho M; Nunes RG; Abreu D; Guedes LC; Bouça R; Lobo PP; Godinho C; Coelho M; Gonçalves NC; Rosa MM; Antonini A; Ferreira JJ
    J Parkinsons Dis; 2017; 7(3):491-501. PubMed ID: 28671143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients.
    Reimão S; Pita Lobo P; Neutel D; Correia Guedes L; Coelho M; Rosa MM; Ferreira J; Abreu D; Gonçalves N; Morgado C; Nunes RG; Campos J; Ferreira JJ
    Eur J Neurol; 2015 Mar; 22(3):540-6. PubMed ID: 25534480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for Dopamine Abnormalities in the Substantia Nigra in Cocaine Addiction Revealed by Neuromelanin-Sensitive MRI.
    Cassidy CM; Carpenter KM; Konova AB; Cheung V; Grassetti A; Zecca L; Abi-Dargham A; Martinez D; Horga G
    Am J Psychiatry; 2020 Nov; 177(11):1038-1047. PubMed ID: 32854531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic Resonance Imaging Biomarkers to Assess Substantia Nigra Damage in Idiopathic Rapid Eye Movement Sleep Behavior Disorder.
    Pyatigorskaya N; Gaurav R; Arnaldi D; Leu-Semenescu S; Yahia-Cherif L; Valabregue R; Vidailhet M; Arnulf I; Lehéricy S
    Sleep; 2017 Nov; 40(11):. PubMed ID: 28958075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparison of Substantia Nigra T1 Hyperintensity in Parkinson's Disease Dementia, Alzheimer's Disease and Age-Matched Controls: Volumetric Analysis of Neuromelanin Imaging.
    Moon WJ; Park JY; Yun WS; Jeon JY; Moon YS; Kim H; Kwak KC; Lee JM; Han SH
    Korean J Radiol; 2016; 17(5):633-40. PubMed ID: 27587951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease.
    Schwarz ST; Rittman T; Gontu V; Morgan PS; Bajaj N; Auer DP
    Mov Disord; 2011 Aug; 26(9):1633-8. PubMed ID: 21491489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromelanin imaging analyses of the substantia nigra in patients with Machado-Joseph disease.
    Nakata Y; Sakamoto A; Kawata A
    Neuroradiology; 2020 Nov; 62(11):1433-1439. PubMed ID: 32556403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson's disease.
    Biondetti E; Gaurav R; Yahia-Cherif L; Mangone G; Pyatigorskaya N; Valabrègue R; Ewenczyk C; Hutchison M; François C; Arnulf I; Corvol JC; Vidailhet M; Lehéricy S
    Brain; 2020 Sep; 143(9):2757-2770. PubMed ID: 32856056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance correlation of iron content with neuromelanin in the substantia nigra of early-stage Parkinson's disease.
    Reimão S; Ferreira S; Nunes RG; Pita Lobo P; Neutel D; Abreu D; Gonçalves N; Campos J; Ferreira JJ
    Eur J Neurol; 2016 Feb; 23(2):368-74. PubMed ID: 26518135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing neuromelanin contrast in the substantia nigra and locus coeruleus using a magnetization transfer contrast prepared 3D gradient recalled echo sequence.
    Liu Y; Li J; He N; Chen Y; Jin Z; Yan F; Haacke EM
    Neuroimage; 2020 Sep; 218():116935. PubMed ID: 32413460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease.
    Reimão S; Pita Lobo P; Neutel D; Guedes LC; Coelho M; Rosa MM; Azevedo P; Ferreira J; Abreu D; Gonçalves N; Nunes RG; Campos J; Ferreira JJ
    Mov Disord; 2015 Jun; 30(7):953-9. PubMed ID: 25758364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quantitative investigation of the substantia nigra in Huntington's disease.
    Oyanagi K; Takeda S; Takahashi H; Ohama E; Ikuta F
    Ann Neurol; 1989 Jul; 26(1):13-9. PubMed ID: 2528318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproducibility assessment of neuromelanin-sensitive magnetic resonance imaging protocols for region-of-interest and voxelwise analyses.
    Wengler K; He X; Abi-Dargham A; Horga G
    Neuroimage; 2020 Mar; 208():116457. PubMed ID: 31841683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesostriatal Dopaminergic Circuit Dysfunction in Schizophrenia: A Multimodal Neuromelanin-Sensitive Magnetic Resonance Imaging and [
    Vano LJ; McCutcheon RA; Rutigliano G; Kaar SJ; Finelli V; Nordio G; Wellby G; Sedlacik J; Statton B; Rabiner EA; Ye R; Veronese M; Hopkins SC; Koblan KS; Everall IP; Howes OD
    Biol Psychiatry; 2024 Oct; 96(8):674-683. PubMed ID: 38942349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A distinct neuromelanin magnetic resonance imaging pattern in parkinsonian multiple system atrophy.
    Simões RM; Castro Caldas A; Grilo J; Correia D; Guerreiro C; Pita Lobo P; Valadas A; Fabbri M; Correia Guedes L; Coelho M; Rosa MM; Ferreira JJ; Reimão S
    BMC Neurol; 2020 Nov; 20(1):432. PubMed ID: 33243166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative Analysis Versus Visual Assessment of Neuromelanin MR Imaging for the Diagnosis of Parkinson's disease.
    Reimão S; Pita Lobo P; Neutel D; Guedes LC; Coelho M; Rosa MM; Ferreira J; Abreu D; Gonçalves N; Morgado C; Nunes RG; Campos J; Ferreira JJ
    J Parkinsons Dis; 2015; 5(3):561-7. PubMed ID: 26406136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromelanin-sensitive magnetic resonance imaging features of the substantia nigra and locus coeruleus in de novo Parkinson's disease and its phenotypes.
    Wang J; Li Y; Huang Z; Wan W; Zhang Y; Wang C; Cheng X; Ye F; Liu K; Fei G; Zeng M; Jin L
    Eur J Neurol; 2018 Jul; 25(7):949-e73. PubMed ID: 29520900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal assessment of nigrosomal degeneration in Parkinson's disease.
    Langley J; Huddleston DE; Crosson B; Song DD; Factor SA; Hu X
    Parkinsonism Relat Disord; 2020 Nov; 80():102-107. PubMed ID: 32979784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.